Alessia Di Sapio

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

Maria Pia Sormani, Matilde Inglese, Irene Schiavetti et al. · EBioMedicine · 2021 · 223 citations · Full text

Persistent neutralizing antibodies abolish the interferon β bioavailability in MS patients

Antonio Bertolotto, Francesca Gilli, Arianna Sala et al. · Neurology · 2003 · 170 citations

Neutralizing antibodies reduce the efficacy of βIFN during treatment of multiple sclerosis

Simona Malucchi, Arianna Sala, Francesca Gilli et al. · Neurology · 2004 · 152 citations

Learning from Nature: Pregnancy Changes the Expression of Inflammation-Related Genes in Patients with Multiple Sclerosis

Francesca Gilli, Raija L.P. Lindberg, Paola Valentino et al. · PLoS ONE · 2010 · 90 citations · Full text

Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy

Maria Pia Sormani, Irene Schiavetti, Matilde Inglese et al. · EBioMedicine · 2022 · 82 citations · Full text